Dr. Yun-Fei Xia

Claim this profile

Sun Yat-sen University Cancer Center

Studies Nasopharyngeal Carcinoma
Studies EBV Infection
1 reported clinical trial
5 drugs studied

Area of expertise

1Nasopharyngeal Carcinoma
Yun-Fei Xia has run 1 trial for Nasopharyngeal Carcinoma. Some of their research focus areas include:
Stage II
Stage III
Stage IV
2EBV Infection
Yun-Fei Xia has run 1 trial for EBV Infection. Some of their research focus areas include:
Stage II
Stage III
Stage IV

More about Yun-Fei Xia

Clinical Trial Related10 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Yun-Fei Xia has experience with
  • Cisplatin
  • Fluorouracil
  • Gemcitabine Hydrochloride
  • Intensity-Modulated Radiation Therapy
  • Paclitaxel

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yun-Fei Xia specialize in?
Yun-Fei Xia focuses on Nasopharyngeal Carcinoma and EBV Infection. In particular, much of their work with Nasopharyngeal Carcinoma has involved Stage II patients, or patients who are Stage III.
Is Yun-Fei Xia currently recruiting for clinical trials?
No, Yun-Fei Xia is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Yun-Fei Xia has studied deeply?
Yes, Yun-Fei Xia has studied treatments such as Cisplatin, Fluorouracil, Gemcitabine Hydrochloride.
What is the best way to schedule an appointment with Yun-Fei Xia?
Apply for one of the trials that Yun-Fei Xia is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.